Associations of High-Density Lipoprotein Functionality with Coronary Plaque Characteristics in Diabetic Patients with Coronary Artery Disease: Integrated Backscatter Intravascular Ultrasound Analysis.
Kohei Takata; Satoshi Imaizumi; Atsushi Iwata; Bo Zhang; Emi Kawachi; Shin-Ichiro Miura; Masahiro Ogawa
Biomolecules, 22 Aug. 2023

HDL Mimetics Enhances Mitochondrial Function via Stimulation of PGC1-α
Hang Zhang; Tomohiro Komatsu; Shihoko Nakashima; Satomi Abe; Emi Kawachi; Satoshi Imaizumi; Keijiro Saku; Yoshinari Uehara
European Cardiology Review, 25 Apr. 2023

Correction to: Randomized trial of an increased dose of calcium channel blocker or angiotensin II type 1 receptor blocker as an add-on intensive depressor therapy in type 2 diabetes mellitus patients with uncontrolled essential hypertension: the ACADEMIE Study.
Satoshi Imaizumi; Yuhei Shiga; Masahiro Ogawa; Hideto Sako; Yoshihisa Nagata; Akira Matsunaga; Tetsuro Shirotani; Fumihiro Hoshino; Eiji Yahiro; Yuko Uehara; Natsumi Morito; Hiroyuki Tanigawa; Dai Shimono; Mikio Fukushima; Hidekazu Sugihara; Kenji Norimatsu; Takaaki Kusumoto; Keijiro Saku; Shin-Ichiro Miura
Heart and vessels, Apr. 2020

ApoA-I模倣ペプチドFAMPと超音波/マイクロバブルを併用した新規動脈硬化治療
今泉聡; 池周而
福岡大学研究部論集, Dec. 2019

Randomized trial of an increased dose of calcium channel blocker or angiotensin II type 1 receptor blocker as an add-on intensive depressor therapy in type 2 diabetes mellitus patients with uncontrolled essential hypertension: the ACADEMIE Study.
Satoshi Imaizumi; Yuhei Shiga; Masahiro Ogawa; Hideto Sako; Yoshihisa Nagata; Akira Matsunaga; Tetsuro Shirotani; Fumihiro Hoshino; Eiji Yahiro; Yuko Uehara; Natsumi Morito; Hiroyuki Tanigawa; Dai Shimono; Mikio Fukushima; Hidekazu Sugihara; Kenji Norimatsu; Takaaki Kusumoto; Keijiro Saku; Shin-Ichiro Miura
Heart and vessels, Apr. 2019

PCSK9を標的とした冠動脈疾患治療戦略 Part（Ⅰ）
桑野孝志; 今泉聡; 野瀬大補; 岩田敦; 池周而; 杉原充; 朔啓二郎; 三浦伸一郎
Research, Mar. 2019

Discontinuation of LDL apheresis with evolocumab in an FH patient with a duplication of exon 2-6 in the LDLR gene.
Nose D; Hori M; Miyamoto Y; Imaizumi S; Harada-Shiba M; Saku K; Miura SI
Journal of cardiology cases, Feb. 2019, Refereed

Anti-atherosclerotic Effects of an Improved Apolipoprotein A-I Mimetic Peptide.
Suematsu Y; Kawachi E; Idemoto Y; Matsuo Y; Kuwano T; Kitajima K; Imaizumi S; Kawamura A; Saku K; Uehara Y; Miura S
Int J Cardiol., 2019

Influence of chronic kidney disease on coronary plaque components in coronary artery disease patients with both diabetes mellitus and hypertension.
Shigemoto E; Iwata A; Futami M; Kato Y; Yamashita M; Imaizumi S; Kuwano T; Ike A; Sugihara M; Saku K; Miura SI
Heart Vessels., Jan. 2019

Impact of cigarette smoking cessation on plasma α-klotho levels.
Kamizono Y; Shiga Y; Suematsu Y; Imaizumi S; Tsukahara H; Noda K; Kuwano T; Fujimi K; Saku K; Miura SI
Medicine (Baltimore)., Aug. 2018

コレステロールを変化させず、炎症を抑えることができたら心臓病はどうなるか？
今泉聡; 朔啓二郎; 三浦伸一郎
Modern Physician, Jul. 2018

CETP 阻害薬アナセトラピブの臨床試験効果：REVEAL trial
今泉聡; 朔啓二郎; 三浦伸一郎
Modern Physician, Jun. 2018

Impact of the triglyceride level on coronary plaque components in female patients with coronary artery disease treated with statins.
Yamashita, M; Iwata, A; Kato, Y; Futami, M; Imaizumi, S; Kuwano, T; Ike, A; Sugihara, M; Nishikawa, H; Zhang, B; Yasunaga, S; Saku, K; Miura, S.I
Heart Vessels, 25 Apr. 2018, Refereed

急性心不全患者における入院中の体重変化は予後を予測する
小牧智; 三浦伸一郎; 今泉聡; 朔啓二郎
福岡県医学会総会記録集, 04 Feb. 2018

Correction to: Association between discordance of LDL-C and non-HDL-C and clinical outcomes in patients with stent implantation: from the FU-Registry.
Shiiba M; Zhang B; Miura SI; Ike A; Nose D; Kuwano T; Imaizumi S; Sugihara M; Iwata A; Nishikawa H; Kawamura A; Shirai K; Yasunaga S; Saku K
Heart Vessels., Feb. 2018

Association between discordance of LDL-C and non-HDL-C and clinical outcomes in patients with stent implantation: from the FU-Registry
Michiyo Shiiba; Bo Zhang; Shin-ichiro Miura; Amane Ike; Daisuke Nose; Takashi Kuwano; Satoshi Imaizumi; Makoto Sugihara; Atushi Iwata; Hiroaki Nishikawa; Akira Kawamura; Kazuyuki Shirai; Shin’ichiro Yasunaga; Keijiro Saku
Heart and Vessels, 01 Feb. 2018

Impact of Von Willebrand Factor on Coronary Plaque Burden in Coronary Artery Disease Patients Treated with Statins.
Kato Y, Iwata A, Futami M, Yamashita M, Imaizumi S, Kuwano T, Ike A, Sugihara M, Nishikawa H, Zhang B, Yasunaga S, Saku K and Miura SI
Medicine., 2018

リバーロキサバンとアスピリン併用の有用性：COMPASS trial
長田 芳久、今泉聡、三浦伸一郎
モダンフィジシャン, 2018

Advanced glycation of high-density lipoprotein and the functionality of aldosterone release in type 2 diabetes
Takashi Kuwano; Shin-ichiro Miura; Kenji Norimatsu; Tadaaki Arimura; Yuhei Shiga; Sayo Tomita; Asuka Nakayama; Yoshino Matsuo; Satoshi Imaizumi; Keijiro Saku
HYPERTENSION RESEARCH, Mar. 2017

Evaluation of the antithrombotic abilities of non-vitamin K antagonist oral anticoagulants using the Total Thrombus-formation Analysis System®.
Yoshiaki Idemoto; Shin-ichiro Miura; Kenji Norimatsu; Yasunori Suematsu; Yuka Hitaka; Yuhei Shiga; Joji Morii; Satoshi Imaizumi; Takashi Kuwano; Atsushi Iwata; Bo Zhang; Masahiro Ogawa; Keijiro Saku
HEART AND VESSELS, Mar. 2017

Significance of the percentage of cholesterol efflux capacity and total cholesterol efflux capacity in patients with or without coronary artery disease
Kenji Norimatsu; Takashi Kuwano; Shin-ichiro Miura; Tomohiko Shimizu; Yuhei Shiga; Yasunori Suematsu; Yuiko Miyase; Sen Adachi; Ayumi Nakamura; Satoshi Imaizumi; Atsushi Iwata; Hiroaki Nishikawa; Yoshinari Uehara; Keijiro Saku
HEART AND VESSELS, Jan. 2017

Improved 68Ga‐labeling method using ethanol addition: Application to the α‐helical peptide DOTA‐FAMP.
Koki Hasegawa; Emi Kawachi; Yoshinari Uehara; Tsuyoshi Yoshida; Satoshi Imaizumi; Masahiro Ogawa; Shin-ichiro Miura; Keijiro Saku
Journal of Labelled Compounds and Radiopharmaceuticals, Jan. 2017

Successful Catheter Ablation of Two Distinct Premature Ventricular Complexes Arising from Right Ventricular Outflow Tract Guided by EnSite NavX 3-D Mapping System with Multielectrode Basket Catheter.
Matsumoto N; Ogawa M; Morii J; Nagata Y; Imaizumi S; Matsunaga A; Saku K
福岡大学医学紀要, 2017

新規抗凝固薬(Non-vitamin K antagonist oral anticoagulants:NOAC)の臨床的有効性評価法の確立
井手元良彰; 杉原英和; 三浦伸一郎; 則松賢次; 末松保憲; 日高有香; 志賀悠平; 森井誠士; 今泉聡; 桑野孝志; 岩田敦; 張波; 小川正浩; 安永晋一郎; 朔啓二郎
福岡大学研究推進部ニュース&レポート, 2017

Effects of dipeptidyl peptidase-4 inhibitor sitagliptin on coronary atherosclerosis as assessed by intravascular ultrasound in type 2 diabetes mellitus with coronary artery disease
Kato Y; Iwata A; Zhang B; Miura S; Imaizumi S; Kuwano T; Ike A; Sugihara M; Nishikawa H; Yasunaga S; Saku K
IJC Metab Endocr, 2017

The Change in Body Weight During Hospitalization Predicts Mortality in Patients With Acute Decompensated Heart Failure.
Komaki T; Miura S; Arimura T; Shiga Y; Morii J; Kuwano T; Imaizumi S; Kitajima K; Iwata A; Morito N; Yahiro E; Fujimi K; Matsunaga A; Saku K
J Clin Med Res, 2017

Improved 68 Ga-labeling method using ethanol addition: Application to the α-helical peptide DOTA-FAMP.
Koki Hasegawa; Emi Kawachi; Yoshinari Uehara; Tsuyoshi Yoshida; Satoshi Imaizumi; Masahiro Ogawa; Shin-ichiro Miura; Keijiro Saku
Journal of Labelled Compounds and Radiopharmaceuticals, Jan. 2017

Circadian variations in laboratory measurements of coagulation assays after administration of rivaroxaban or warfarin in patients with nonvalvular atrial fibrillation
Yuka Hitaka; Masahiro Ogawa; Bo Zhang; Shunichiro Goto; Yoshihisa Nagata; Joji Morii; Satoshi Imaizumi; Tomoo Yasuda; Naomichi Matsumoto; Akira Matsunaga; Keijiro Saku
JOURNAL OF CARDIOLOGY, Nov. 2016

Rivaroxaban, a factor Xa inhibitor, induces the secondary prevention of cardiovascular events after myocardial ischemia reperfusion injury in mice
Masaki Goto; Shin-ichiro Miura; Yasunori Suematsu; Yoshiaki Idemoto; Kouhei Takata; Satoshi Imaizumi; Yoshinari Uehara; Keijiro Saku
INTERNATIONAL JOURNAL OF CARDIOLOGY, Oct. 2016

Association between cholesterol efflux capacity and coronary restenosis after successful stent implantation
Satoshi Imaizumi; Shin-ichiro Miura; Kohei Takata; Yosuke Takamiya; Takashi Kuwano; Makoto Sugihara; Amane Ike; Atsushi Iwata; Hiroaki Nishikawa; Keijiro Saku
HEART AND VESSELS, Aug. 2016

LCZ696, an angiotensin receptor-neprilysin inhibitor, improves cardiac function with the attenuation of fibrosis in heart failure with reduced ejection fraction in streptozotocin-induced diabetic mice
Yasunori Suematsu; Shin-ichiro Miura; Masaki Goto; Yoshino Matsuo; Tadaaki Arimura; Takashi Kuwano; Satoshi Imaizumi; Atsushi Iwata; Eiji Yahiro; Keijiro Saku
EUROPEAN JOURNAL OF HEART FAILURE, Apr. 2016

The ApoA-I mimetic peptide FAMP promotes recovery from hindlimb ischemia through a nitric oxide (NO)-related pathway
Kohei Takata; Satoshi Imaizumi; Emi Kawachi; Eiji Yahiro; Yasunori Suematsu; Tomohiko Shimizu; Satomi Abe; Yoshino Matsuo; Kyoko Nakajima; Tetsuhiko Yasuno; Shiro Jimi; Bo Zhang; Yoshinari Uehara; Shin-ichiro Miura; Keijiro Saku
INTERNATIONAL JOURNAL OF CARDIOLOGY, Mar. 2016

Stabilization of high-risk plaques
Kohei Takata; Satoshi Imaizumi; Bo Zhang; Shin-Ichiro Miura; Keijiro Saku
Cardiovascular Diagnosis and Therapy, 2016

Frequent Premature Ventricular Complexes Originating from the Left Ventricular Summit Successfully Ablated from the Proximal Great Cardiac Vein Using an Impedance-based Electroanatomical Mapping System
Yoshihisa Nagata; Masahiro Ogawa; Shunichiro Goto; Joji Morii; Satoshi Imaizumi; Tomoo Yasuda; Naomichi Matsumoto; Keijiro Saku
INTERNAL MEDICINE, 2016

第14回禁煙推進セミナー／病院・医学部・学会・自治体での禁煙推進術
今泉聡; 桑野孝志; 森戸夏美; 朔啓二郎
循環器専門医, 2016

HDLの多面的機能と動脈硬化
今泉聡; 高田耕平; 朔啓二郎
Total Vascular Management, 2016

新規開発のトリガー分子を探せ！ApoA-I
今泉聡; 朔啓二郎
メディカル・ビューポイント, 2016

Residual Riskに対するHDL増加・機能改善療法における包括的心臓リハビリテーションの役割
三浦伸一郎; 藤見幹太; 有村忠聴; 志賀悠平; 今泉聡; 北島研; 朔啓二郎
日本心臓リハビリテーション学会誌, 2016

Addition of a Nitric Oxide Donor to an Angiotensin II Type 1 Receptor Blocker May Cancel Its Blood Pressure-Lowering Effects
Eiji Yahiro; Shin-ichiro Miura; Yasunori Suematsu; Yoshino Matsuo; Tadaaki Arimura; Takashi Kuwano; Satoshi Imaizumi; Atsushi Iwata; Yoshinari Uehara; Keijiro Saku
INTERNATIONAL HEART JOURNAL, Nov. 2015

Newly developed apolipoprotein A-I mimetic peptide promotes macrophage reverse cholesterol transport in vivo
Tomohiko Shimizu; Hiroyuki Tanigawa; Shin-ichiro Miura; Takashi Kuwano; Kohei Takata; Yasunori Suematsu; Satoshi Imaizumi; Eiji Yahiro; Bo Zhang; Yoshinari Uehara; Keijiro Saku
INTERNATIONAL JOURNAL OF CARDIOLOGY, Aug. 2015

高齢患者に対して様々な心臓超音波を用いて有効かつ安全にカテーテルアブレーションを施行した1例
長田 芳久; 森井 誠士; 日高 友香; 今泉 聡; 安田 智生; 松本 直通; 小川 正浩; 朔 啓二郎
超音波医学, Jan. 2015

新規HDL-C増加薬(2) 合成HDLとミメティックペプチド.
IMAIZUMI Satoshi; UEHARA Yoshinari; SAKU Keijiro
血管医学, 2015

コレステロール引き抜き能と心血管疾患.
IMAIZUMI Satoshi; SAKU Keijiro
モダンフィジシャン, 2015

The Use of Multiplex Ligation Dependent Probe Amplification Technology for Genetic Analysis of the Entire PKD1 Gene and PKD2 Gene.
YASUNO Tetsuhiko; IMAIZUMI Satoshi
J Clin Med Case Reports, 2015

Comparison of 64Cu and 68Ga for Molecular Imaging of Atherosclerosis using the Apolipoprotein A-I Mimetic Peptide FAMP.
Yahiro E, Kawachi E, Miura S, Kuwano T, Imaizumi S, Iwata A, Hasegawa K, Yano T, Watanabe Y, Uehara Y, Saku K
J Cardiovasc Dis Diag., 2015

A novel inducible cholesterol efflux peptide, FAMP, protects against myocardial ischemia reperfusion injury through a nitric oxide pathway.
Suematsu Y, Miura SI, Takata K, Shimizu T, Kuwano T, Imaizumi S, Matsuo Y, Yahiro E, Uehara Y, Saku K.
Int J Cardiol., 2015

心不全におけるスタチンの効果
今泉聡; 朔啓二郎
モダンフィジシャン, 2015

Impact of Cigarette Smoking Cessation on High-Density Lipoprotein Functionality - VN-SEESAW-HDL -
Kohei Takata; Satoshi Imaizumi; Emi Kawachi; Yasunori Suematsu; Tomohiko Shimizu; Satomi Abe; Yoshino Matsuo; Hitomi Tsukahara; Keita Noda; Eiji Yahiro; Bo Zhang; Yoshinari Uehara; Shin-ichiro Miura; Keijiro Saku
CIRCULATION JOURNAL, Dec. 2014, Refereed

HDL機能と心血管イベント
今泉聡; 朔啓二郎
モダンフィジシャン, 2014

心筋梗塞二次予防のための薬物選択のポイント.
IMAIZUMI Satoshi; SAKU Keijiro
日本医事新報, 2014

肥満の合併症 高血圧・心疾患.
TAKATA Kohei; IMAIZUMI Satoshi; SAKU Keijiro
臨床と研究, 2014

機能不全のアポ蛋白A-Iと動脈硬化.
IMAIZUMI Satoshi; SAKU Keijiro
モダンフィジシャン, 2014

新たな冠動脈ステント再狭窄抑制の可能性.
IMAIZUMI Satoshi; SAKU Keijiro
モダンフィジシャン, 2014

Induction of endothelial tube formation and anti-inflammation by newly developed apolipoprotein A-I mimetic peptide.
Miura S; Suematsu Y; Matsuo Y; Imaizumi S; Yohiro E; Uehara Y; Saku K
IJC Metabolic & Endocrine., 2014

FAMP, a Novel ApoA-I Mimetic Peptide, Suppresses Aortic Plaque Formation Through Promotion of Biological HDL Function in ApoE-Deficient Mice
Yoshinari Uehara; Setsuko Ando; Eiji Yahiro; Kosuke Oniki; Makoto Ayaori; Satomi Abe; Emi Kawachi; Bo Zhang; Seijiro Shioi; Hiroyuki Tanigawa; Satoshi Imaizumi; Shin-ichiro Miura; Keijiro Saku
JOURNAL OF THE AMERICAN HEART ASSOCIATION, Jun. 2013

低HDL血症
高田耕平; 今泉聡; 朔啓二郎
2013

冠動脈疾患患者におけるHDL機能の障害．
今泉聡; 朔啓二郎
モダンフィジシャン, 2013

冠動脈疾患とHDLコレステロール．
今泉聡; 朔啓二郎
Medical Practice, 2013

予防と治療の進め方 低HDL血症への対策．
高田耕平; 今泉聡; 朔啓二郎
medicina, 2013

Recent Progress in Molecular Mechanisms of Angiotensin II Type 1 and 2 Receptors.
Miura S; Imaizumi S; Saku K
Curr Pharm Des., 2013

Class- and Molecule-specific Differential Effects of Angiotensin II Type 1 Receptor Blockers.
Imaizumi S; Miura S; Yahiro E; Uehara Y; Komuro I; Saku K
Curr Pharm Des., 2013

Chymase inhibitors
Eiji Yahiro; Shin-ichiro Miura; Satoshi Imaizumi; Yoshinari Uehara; Keijiro Saku
Current Pharmaceutical Design, 2013

HDL選択的脱脂質化法.
今泉聡; 朔啓二郎
Nippon Rinsho, 2013

動脈硬化の発症・進展と治療薬の可能性．
今泉聡; 朔啓二郎
Vascular Street, 2013

低HDL-C血症への対策
TAKATA Kohei; IMAIZUMI Satoshi; SAKU Keijiro
medicina, 2013

Macrophage paraoxonase 2 regulates calcium homeostasis and cell survival under endoplasmic reticulum stress conditions and is sufficient to prevent the development of aggravated atherosclerosis in paraoxonase 2 deficiency/apoE(-/-) mice on a Western diet
Asokan Devarajan; Victor R. Grijalva; Noam Bourquard; David Meriwether; Satoshi Imaizumi; Bo-Chul Shin; Sherin U. Devaskar; Srinivasa T. Reddy
MOLECULAR GENETICS AND METABOLISM, Nov. 2012, Refereed

Reactivity of Direct Assays for Low-Density Lipoprotein (LDL) Cholesterol Toward Charge-Modified LDL in Hypercholesterolemia
Bo Zhang; Emi Kawachi; Akira Matsunaga; Satoshi Imaizumi; Keita Noda; Yoshinari Uehara; Shin-ichiro Miura; Kazuhiko Yoshinaga; Masahide Kuroki; Keijiro Saku
CIRCULATION JOURNAL, Sep. 2012, Refereed

Small Molecules with Similar Structures Exhibit Agonist, Neutral Antagonist or Inverse Agonist Activity toward Angiotensin II Type 1 Receptor
Shin-ichiro Miura; Yoshihiro Kiya; Hiroyuki Hanzawa; Naoki Nakao; Masahiro Fujino; Satoshi Imaizumi; Yoshino Matsuo; Hiroaki Yanagisawa; Hiroyuki Koike; Issei Komuro; Sadashiva S. Karnik; Keijiro Saku
PLOS ONE, Jun. 2012, Refereed

HDL Mimetics Inhibit Tumor Development in Both Induced and Spontaneous Mouse Models of Colon Cancer
Feng Su; Victor Grijalva; Kaveh Navab; Ekambaram Ganapathy; David Meriwether; Satoshi Imaizumi; Mohamad Navab; Alan M. Fogelman; Srinivasa T. Reddy; Robin Farias-Eisner
MOLECULAR CANCER THERAPEUTICS, Jun. 2012, Refereed

特集 先進循環器病治療研究会 「血管を護るための糖尿病治療戦略〜インクレチン関連薬を中心に〜」
朔啓二郎; 野見山崇; 仁位隆信; 岡部眞典; 白井和之; 小川正浩; 上原吉就; 河村彰; 西川宏明; 岩田敦; 佐光英人; 安田智生; 藤見幹太; 森戸夏美; 八尋英二; 光武良晃; 今泉聡
Vascular Street, 2012

抗酸化、抗糖化因子と血管医学 パラオキソナーゼ．
今泉聡; 鬼木幸祐; 朔啓二郎
血管医学, 2012

TG-rich HDL.
今泉聡; 上原吉就; 朔啓二郎
Heart View, 2012

降圧療法におけるARB/利尿薬配合錠の有用性．
三浦伸一郎; 志賀悠平; 今泉聡; 上原吉就; 朔啓二郎
Progress in Medicine 第10号 別刷, 2012

ミトコンドリアDNAによる心不全．
今泉聡; 朔啓二郎
モダンフィジシャン, 2012

腸内細菌叢と動脈硬化．
今泉聡; 朔啓二郎
モダンフィジシャン, 2012

Antiatherogenic effects of newly developed apolipoprotein A-I mimetic peptide/phospholipid complexes against aortic plaque burden in Watanabe-heritable hyperlipidemic rabbits
Atsushi Iwata; Shin-ichiro Miura; Bo Zhang; Satoshi Imaizumi; Yoshinari Uehara; Masashi Shiomi; Keijiro Saku
ATHEROSCLEROSIS, Oct. 2011

Enhancement by LDL of transfer of L-4F and oxidized lipids to HDL in C57BL/6J mice and human plasma
David Meriwether; Satoshi Imaizumi; Victor Grijalva; Greg Hough; Ladan Vakili; G. M. Anantharamaiah; Robin Farias-Eisner; Mohamad Navab; Alan M. Fogelman; Srinivasa T. Reddy; Ishaiahu Shechter
JOURNAL OF LIPID RESEARCH, Oct. 2011, Refereed

Dysfunctional High-Density Lipoprotein and the Potential of Apolipoprotein A-1 Mimetic Peptides to Normalize the Composition and Function of Lipoproteins
Satoshi Imaizumi; Mohamad Navab; Cecilia Morgantini; Christina Charles-Schoeman; Feng Su; Feng Gao; Murray Kwon; Ekambaram Ganapathy; David Meriwether; Robin Farias-Eisner; Alan M. Fogelman; Srinivasa T. Reddy
CIRCULATION JOURNAL, Jul. 2011, Refereed

Intestine may be a major site of action for the apoA-I mimetic peptide 4F whether administered subcutaneously or orally
Mohamad Navab; Srinivasa T. Reddy; G. M. Anantharamaiah; Satoshi Imaizumi; Greg Hough; Susan Hama; Alan M. Fogelman
JOURNAL OF LIPID RESEARCH, Jun. 2011, Refereed

Human CYP2S1 Metabolizes Cyclooxygenase- and Lipoxygenase-Derived Eicosanoids
Peter Bui; Satoshi Imaizumi; Sudheer Reddy Beedanagari; Srinivasa T. Reddy; Oliver Hankinson
DRUG METABOLISM AND DISPOSITION, Feb. 2011, Refereed

Anti-inflammatory and antioxidant properties of hdls are impaired in type 2 diabetes.
Morgantini C; Natali A; Boldrini B; Imaizumi S; Navab M; Fogelman AM; Ferrannini E; Reddy ST
Diabetes., 2011, Refereed

L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways
Feng Gao; Sergio X. Vasquez; Feng Su; Svetlana Roberts; Neha Shah; Victor Grijalva; Satoshi Imaizumi; Arnab Chattopadhyay; Ekambaram Ganapathy; David Meriwether; Brad Johnston; G. M. Anantharamaiah; Mohamad Navab; Alan M. Fogelman; Srinivasa T. Reddy; Robin Farias-Eisner
INTEGRATIVE BIOLOGY, 2011, Refereed

脾臓の意外な役割
今泉聡; 朔啓二郎
モダンフィジシャン, 2011

HDL研究からHDL治療へ
朔啓二郎; 上原吉就; 三浦伸一郎; 谷川宏之; 張波; 木谷嘉博; 今泉聡; Srinivasa T. Reddy
循環器専門医, 2011

Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer
Feng Su; Kathy R. Kozak; Satoshi Imaizumi; Feng Gao; Malaika W. Amneus; Victor Grijalva; Carey Ng; Alan Wagner; Greg Hough; Gina Farias-Eisner; G. M. Anantharamaiah; Brian J. Van Lenten; Mohamad Navab; Alan M. Fogelman; Srinivasa T. Reddy; Robin Farias-Eisner
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, Nov. 2010, Refereed

Mitogen-activated protein kinase phosphatase-1 deficiency decreases atherosclerosis in apolipoprotein E null mice by reducing monocyte chemoattractant protein-1 levels
Satoshi Imaizumi; Victor Grijalva; Saul Priceman; Lily Wu; Feng Su; Robin Farias-Eisner; Susan Hama; Mohamad Navab; Alan M. Fogelman; Srinivasa T. Reddy
MOLECULAR GENETICS AND METABOLISM, Sep. 2010, Refereed

ApoA-I Mimetic Peptides Prevent Atherosclerosis Development in a Mouse Model of Diabetes
Morgantini C; Imaizumi S; Grijalva V; Navab M; Fogelman AM; Reddy ST
DIABETES, Jun. 2010, Refereed

L-4F Alters Hyperlipidemic (But Not Healthy) Mouse Plasma to Reduce Platelet Aggregation
Georgette M. Buga; Mohamad Navab; Satoshi Imaizumi; Srinivasa T. Reddy; Babak Yekta; Greg Hough; Shawn Chanslor; G. M. Anantharamaiah; Alan M. Fogelman
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, Feb. 2010, Refereed

L-4f differentially alters plasma levels of oxidized fatty acids resulting in more anti-inflammatory hdl in mice.
Imaizumi S; Grijalva V; Navab M; Van Lenten BJ; Wagner AC; Anantharamiah GM; Fogelman AM; Reddy ST
Drug Metab Lett., 2010, Refereed

Pharmacological Intervention Using Reconstituted High-Density Lipoprotein Changes in the Lipid Profile in Spontaneously Hypersensitive Rats
Satoshi Imaizumi; Yoshihiro Kiya; Shin-Ichiro Miura; Bo Zhang; Yoshino Matsuo; Yoshinari Uehara; Kerry-Anne Rye; Keijiro Saku
CLINICAL AND EXPERIMENTAL HYPERTENSION, 2010, Refereed

Clinical and Pharmacotherapeutic Relevance of the Double-Chain Domain of the Angiotensin Ⅱ Type 1 Receptor Blocker Olmesartan
Yoshihiro Kiya; Shin-ichiro Miura; Masahiro Fujino; Satoshi Imaizumi; Sadashiva S. Karnik; Keijiro Saku
CLINICAL AND EXPERIMENTAL HYPERTENSION, 2010

Reconstituted high-density lipoprotein attenuates postinfarction left ventricular remodeling in rats
Yoshihiro Kiya; Shin-ichiro Miura; Satoshi Imaizumi; Yoshinari Uehara; Yoshino Matsuo; Satomi Abe; Shiro Jimi; Hidenori Urata; Kerry-Anne Rye; Keijiro Saku
ATHEROSCLEROSIS, Mar. 2009, Refereed

Antiarrhythmogenic effect of reconstituted high-density lipoprotein against ischemia/reperfusion in rats
Satoshi Imaizumi; Shin-ichiro Miura; Kazuto Nakamura; Yoshihiro Kiya; Yoshinari Uehara; Bo Zhang; Yoshino Matsuo; Hidenori Urata; Munehito Idelshi; Kerry-Anne Rye; Masataka Sata; Keijiro Saku
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, Apr. 2008, Refereed

Conformational switch of angiotensinⅡ type1 receptor underlying mechanical stress-induced activation
Noritaka Yasuda; Shin-ichiro Miura; Hiroshi Akazawa; Toshimasa Tanaka; Yingjie Qin; Yoshihiro Kiya; Satoshi Imaizumi; Masahiro Fujino; Kaoru Ito; Yunzeng Zou; Shigetomo Fukuhara; Satoshi Kunimoto; Koichi Fukuzaki; Toshiaki Sato; Junbo Ge; Naoki Mochizuki; Haruaki Nakaya; Keijiro Saku; Issei Komuro
EMBO REPORTS, Feb. 2008

世界のトップジャーナルから
Imaizumi Satoshi; Kiya Yoshihiro; Takamiya Yosuke; Mito Takahiro; Kuwano Takashi; Noda Keita; Saku Keijiro
Nihon Naika Gakkai Kaishi, 2008

アンジオテンシン1受容体拮抗薬によるマルファン症候群の治療
今泉聡; 朔啓二郎
Medical Practice, 2008

世界のトップジャーナルから
有島宏明; 木谷嘉博; 福田佑介; 今泉聡; 桑野孝志; 野田慶太; 朔啓二郎
日本内科学会雑誌, 2008

Differential Bonding Interactions of Inverse Agonists of AngiotensinⅡ Type1 Receptor in Stabilizing the Inactive State
Shin-ichiro Miura; Yoshihiro Kiya; Takanori Kanazawa; Satoshi Imaizumi; Masahiro Fujino; Yoshino Matsuo; Sadashiva S. Karnik; Keijiro Saku
MOLECULAR ENDOCRINOLOGY, Jan. 2008

世界のトップジャーナルから
今泉聡; 木谷嘉博; 高宮陽介; 三戸隆裕; 桑野孝志; 野田慶太; 朔啓二郎
日本内科学会雑誌, 2008

世界のトップジャーナルから
桑野孝志; 今泉聡; 木谷嘉博; 高宮陽介; 三戸隆裕; 野田慶太; 朔啓二郎
日本内科学会雑誌, 2008

Relation between charge-based apolipoprotein B-containing lipoprotein subfractions and remnant-like particle cholesterol levels
Bo Zhang; Alfred Boettcher; Satoshi Imaizumi; Keita Noda; Gerd Schmitz; Keijiro Saku
ATHEROSCLEROSIS, Mar. 2007, Refereed

Do valsartan and losartan have the same effects in the treatment of coronary artery disease?
Atsushi Iwata; Shin-ichiro Miura; Satoshi Imaizumi; Yoshihiro Kiya; Hiroaki Nishikawa; Bo Zhang; Hideki Shimomura; Koichiro Kumagai; Kunihiro Matsuo; Kazuyuki Shirai; Keijiro Saku
CIRCULATION JOURNAL, Jan. 2007

Measurement of atherosclerotic plaque volume in hyperlipidemic rabbit aorta by intravascular ultrasound
Atsushi Iwata; Shin-Ichiro Miura; Satoshi Imaizumi; Bo Zhang; Keijiro Saku
Journal of Cardiology, 2007, Refereed

サイトカインによる心筋再生療法
今泉聡; 朔啓二郎
Medical Practice, 2007

ACE阻害薬の冠動脈側副血行促進作用
今泉聡; 朔啓二郎
ModernPhysician, 2007

PPAR-γの活性化と血管内皮機能
今泉聡; 朔啓二郎
Medical Practice, 2007

Molecular Mechanism Underlying Inverse Agonist of AngiotensinⅡ Type1 Receptor
Shin-ichiro Miura; Masahiro Fujino; Hiroyuki Hanzawa; Yoshihiro Kiya; Satoshi Imaizumi; Yoshino Matsuo; Sayo Tomita; Yoshinari Uehara; Sadashiva S. Karnik; Hiroaki Yanagisawa; Hiroyuki Koike; Issei Komuro; Keijiro Saku
JOURNAL OF BIOLOGICAL CHEMISTRY, Jul. 2006

Angiotensin II type 1 receptor blockers do not promote coronary collateral circulation in patients with coronary artery disease
S Imaizumi; S Miura; H Nishikawa; A Iwata; B Zhang; A Kawamura; Y Tsuchiya; K Kumagai; K Matsuo; K Saku
HYPERTENSION RESEARCH, Mar. 2006, Refereed

高脂血症の病態と診断
今泉聡; 朔啓二郎
臨床と研究, 2006

内皮機能に及ぼすHDLの作用
今泉聡; 三浦伸一郎; 朔啓二郎
Cardiac Practice, 2005

高齢にて発見された巨大左房粘液腫の一例
今泉聡; 三浦伸一郎ほか
臨牀と研究, 2004

Inhibition of lipopolysaccharide induced gene expression by HDL from healthy subjects and patients with acute myocardial infarction
S. Imaizumi; K. Takata; E. Yahiro; E. Kawachi; A. Iwata; Y. Uehara; B. Zhang; S. Miura; K. Saku
EUROPEAN HEART JOURNAL, Aug. 2016

Comparison of circadian laboratory measurements of coagulation assays between administrations of rivaroxaban and warfarin in patients with non-valvular atrial fibrillation
Y. Hitaka; M. Ogawa; S. Goto; Y. Nagata; J. Morii; S. Imaizumi; T. Yasuda; N. Matsumoto; A. Matsunaga; K. Saku
EUROPEAN HEART JOURNAL, Aug. 2015

Impact of anti-oxidative capacity of high-density lipoprotein on vulnerability of coronary plaques in patients with type 2 diabetes mellitus
K. Takata; A. Iwata; S. Imaizumi; B. Zhang; S. Miura; K. Saku
EUROPEAN HEART JOURNAL, Aug. 2015

Relation between high-density lipoprotein efflux capacity and coronary plaque progression in type 2 diabetes patients with intensive lipid-lowering therapy
S. Imaizumi; A. Iwata; K. Takata; B. Zhang; S. Miura; K. Saku
EUROPEAN HEART JOURNAL, Aug. 2015

Effect of smoking cessation on HDL function
E. Kawachi; S. Imaizumi; K. Takata; S. Abe; Y. Matsuo; E. Yahiro; Y. Uehara; B. Zhang; S. Miura; K. Saku
EUROPEAN HEART JOURNAL, Sep. 2014

HDL Functionality Could be a Novel Marker for Predicting Restenosis after Stent Implantation
Satoshi Imaizumi; Shin-Ichiro Miura; Yosuke Takamiya; Akira Kawamura; Bo Zhang; Atsushi Iwata; Hiroaki Nishikawa; Kunihiro Matsuo; Kazuyuki Shirai; Yoshinari Uehara; Srinivasa T. Reddy; Keijiro Saku
CIRCULATION, Nov. 2012

Intravenous ApoA-I Mimetic Peptide (ETC-642) Discs Inhibit the Progression of Atherosclerosis in Myocardial Infarction-Prone Watanabe-Heritable Hyperlipidemic (WHHL-MI) Rabbits: An Intravascular Ultrasound Study
Atsushi Iwata; Boo Zhang; Satoshi Imaizumi; Shin-ichiro Miura; Keijiro Saku
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, Mar. 2009

Clinical and pharmacotherapeutic relevance underlying the inverse agonism of angiotensin II type I receptor blocker
S. Miura; M. Fujino; Y. Kiya; Y. Matsuo; S. Imaizumi; S. S. Karnik; K. Saku
JOURNAL OF HYPERTENSION, Jun. 2008

RECONSTITUTED HDL THERAPY FOR CARDIOVASCULAR DISEASE
S. Miura; S. Imaizumi; Y. Kiya; M. Sata; K. A. Rye; K. Saku
ATHEROSCLEROSIS SUPPLEMENTS, May 2008

Molecular basis of the stabilization of angiotensin II type 1 receptor by valsartan
Shin-ichiro Miura; Yoshihiro Kiya; Satoshi Imaizumi; Yoshino Matsuo; Masahiro Fujino; Keijiro Saku
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, Mar. 2008

PE-173 Effects for Metabolic Factors by Reconstituted High-density Lipoprotein in Goto-Kakizaki Rats(Metabolism/Biochemistry/Energetics-1, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
Kiya Yoshihiro; Miura Shin-ichiro; Imaizumi Satoshi; Uehara Yoshinari; Rye Kerry-Anne; Saku Keijiro
Circulation journal : official journal of the Japanese Circulation Society, 01 Mar. 2007

PE-251 Molecular Basis of the Suppression of Reperfusion-induced Arrhythmias by ApolipoproteinA-I Discs(Lipid disorders-2, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
Imaizumi Satoshi; Miura Shinichiro; Kiya Yoshihiro; Uehara Yoshinari; Rye Kerry-Anne; Saku Keijiro
Circulation journal : official journal of the Japanese Circulation Society, 01 Mar. 2007

Peiotropic action of HDL and HDL therapy
S. Miura; Y. Kiya; S. Imaizumi; B. Zhang; Y. Matsuo; Y. Uehara; K. A. Rye; K. Saku
ATHEROSCLEROSIS SUPPLEMENTS, Jun. 2006

Pharmacological intervention using reconstituted high-density lipoprotein changes the lipid profile in spontaneously hypersensitive rats
S. Imaizumi; S. Miura; Y. Kiya; B. Zhang; Y. Uehara; K. A. Rye; K. Saku
ATHEROSCLEROSIS SUPPLEMENTS, Jun. 2006

Intensive lowering of low-density lipoprotein cholesterol prevents the progression of coronary restenosis
A. Iwata; S. Miura; S. Imaizumi; K. Shirai; K. Mori; B. Zhang; H. Nishikawa; K. Mastuo; K. Saku
ATHEROSCLEROSIS SUPPLEMENTS, Jun. 2006

PJ-245 Pharmacological Intervention Using Reconstituted High-density Lipoprotein (rHDL) Changes the Lipid Profile in Spontaneously Hypersensitive Rats (SHR)(Lipid disorders-3 (H) PJ41,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
Imaizumi Satoshi; Miura Shinichiro; Kiya Yoshihiro; Zhang Bo; Uehara Yoshinari; Rye Kerry-Ann; Saku Keijiro
Circulation journal : official journal of the Japanese Circulation Society, 01 Mar. 2006

Apolipoprotein A-I discs may prevent apoptosis through ERK activation in myocytes
Y Kiya; S Miura; S Imaizumi; Y Uehara; Y Matsuo; H Urata; KA Rye; K Saku
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, Dec. 2005

Apolipoprotein A-I discs containing sphingosine-1-phosphate induced coronary artery endothelial tube formation through Akt/ERK/NO pathway
Y Matsuo; S Miura; Y Kiya; S Imaizumi; Y Uehara; KA Rye; K Saku
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, Dec. 2005

Apolipoprotein A-I discs-induced nitric oxide production in coronary endothelial cells may suppress reperfusion-induced arrhythmias in rats
S Imaizumi; S Miura; Y Uehara; Y Kiya; H Urata; KA Rye; K Saku
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, Dec. 2005

ApoA-I discs prevent pathological remodeling after myocardial infarction in rats
Y Kiya; S Miura; S Imaizumi; Y Uehara; KA Rye; K Saku
CIRCULATION, Oct. 2005

Relation between Remnant-like Particle Fraction and Electronegative Low-Density Lipoprotein Subfraction in Patients with Hypercholesterolemia(Atherosclerosis, Clinical 14 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
Zhang Bo; Imaizumi Satoshi; Noda Keita; Matsunaga Akira; Saku Keijiro
Circulation journal : official journal of the Japanese Circulation Society, 01 Mar. 2005

10. 日本医師会 生涯教育シリーズ97 動脈硬化診療のすべて Ⅳ. 動脈硬化研究のトピックス A. 基礎研究 3. カナキヌマブ
今泉 聡
日本医師会, 15 Oct. 2019

循環器疾患 最新の治療2018-2019 XVI ３．脂質異常症（高脂血症）
2018

最新冠動脈疾患学（下）－冠動脈疾患の最新治療戦略― 4. 慢性心筋梗塞 (2)慢性心筋梗塞の治療 1)薬物療法 ②二次予防薬
2016

そうだったんだ！脂質異常症 Ⅰ. One Point Advice. 高HDL血症は高リスク？
2016

そうだったんだ！脂質異常症 Ⅰ. Controversy. 飲酒でHDLが増加する？
2016

EBM 循環器疾患の治療 2015-2016 Ⅳ.高血圧・肺高血圧・脂質異常症 C.脂質異常症 20. HDLを標的とする治療はどこまで進んだのか？
TAKATA Kohei; IMAIZUMI Satoshi; SAKU Keijiro
2015

循環器内科 研修ポケットブック第1版 2014 Ⅱ. 症候 Ⅶ. 弁膜疾患、感染性心内膜炎
2014

循環器病ベストチョイス こんな病態・症例にこの処方. １－１１．脂質異常症治療薬
今泉聡; 朔啓二郎, Joint work
2012

薬剤 脂質異常症治療薬．
今泉聡; 朔啓二郎, Contributor
2012

HDL機能を強化・改善する食事パターン・食品・栄養素の同定
Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research, Grant-in-Aid for Scientific Research (C)
Fukuoka University
01 Apr. 2022 - 31 Mar. 2025

ナノバブル化アポA-I模倣ペプチドと超音波による新規動脈硬化治療法の開発
日本学術振興会, 科学研究費助成事業, 基盤研究(C)
福岡大学
01 Apr. 2018 - 31 Mar. 2023

新規動脈硬化診断指標：LC―MS／MSイソプロスタン分析法の臨床的意義の確立
Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research, Grant-in-Aid for Scientific Research (C)
Fukuoka University
01 Apr. 2017 - 31 Mar. 2020

アポA-I模倣ペプチドによる末梢動脈疾患の多面的治療戦略
Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research, Grant-in-Aid for Young Scientists (B)
Fukuoka University
01 Apr. 2014 - 31 Mar. 2017

新しい動脈硬化診断指標：HDL機能測定の確立と臨床意義の解明
Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research, Grant-in-Aid for Scientific Research (C)
Fukuoka University
01 Apr. 2014 - 31 Mar. 2017

ＨＤＬ機能解析・測定法の確立と臨床応用
Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research, Grant-in-Aid for Young Scientists (B)
Fukuoka University
01 Apr. 2012 - 31 Mar. 2014